Cambridge Investment Research Advisors, Inc. - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 225 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$90
-99.9%
101,326
+1.3%
0.00%
-100.0%
Q3 2022$157,000
-13.3%
100,053
+11.2%
0.00%0.0%
Q2 2022$181,000
-11.3%
89,958
+2.9%
0.00%0.0%
Q1 2022$204,000
-31.1%
87,402
+37.2%
0.00%0.0%
Q4 2021$296,000
-54.0%
63,696
-24.5%
0.00%
-66.7%
Q3 2021$644,000
-22.0%
84,344
-1.1%
0.00%
-25.0%
Q2 2021$826,000
+13.5%
85,276
-3.1%
0.00%0.0%
Q1 2021$728,000
+12.5%
88,026
-7.2%
0.00%0.0%
Q4 2020$647,000
-0.8%
94,832
+62.1%
0.00%0.0%
Q3 2020$652,000
+141.5%
58,506
+36.0%
0.00%
+100.0%
Q2 2020$270,00043,0150.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 6,000,000$66,900,0002.57%
SABBY MANAGEMENT, LLC 606,298$6,760,0001.01%
Virtus ETF Advisers LLC 66,851$745,0000.39%
Newbridge Financial Services Group, Inc. 26,900$300,0000.30%
Avidian Wealth Solutions, LLC 330,000$3,680,0000.28%
Spectrum Wealth Advisory Group, LLC 36,692$422,0000.27%
COWEN AND COMPANY, LLC 129,200$1,441,0000.24%
Cormorant Asset Management, LP 500,000$5,575,0000.21%
SYMMETRY PEAK MANAGEMENT LLC 27,500$307,0000.20%
Aristides Capital LLC 24,302$271,0000.19%
View complete list of SORRENTO THERAPEUTICS INC shareholders